The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...
DELRAY BEACH, Fla., Dec. 9, 2025 /PRNewswire/ — According to MarketsandMarkets™, the global High-end Refractometer Market is ...
Immunostimulant therapies are widely used across preventive care, acute care, and chronic disease management owing to their ...
Amid enormous shifts, many scientists pushed back and risked dismissal from their jobs even as federal agencies fired ...
News-Medical.Net on MSN
EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy
EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing ...
Idorsia’s dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of ...
The "Pharmaceutical Safety Assessment Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The pharmaceutical safety assessment market has demonstrated significant growth, ...
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to become one of the fastest technology adoptions in ...
The global synthetic biology market is poised for exponential growth, driven by a myriad of factors including increasing investments by government and private players, rising R&D funding and ...
Get a Free Sample PDF copy of the report @- https://reportocean.com/industry-verticals/sample-request?report_id=BWC70 ...
PsO is a systemic inflammatory disease that presents not only as scaly skin lesions, erythema, and itching but also affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results